{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.11, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [481, 183, 1193, 188, 1192, 239, 480, 234], "text": "ACTOS FDA Response Strategy", "words": [{"boundingBox": [481, 187, 657, 186, 656, 234, 481, 230], "text": "ACTOS"}, {"boundingBox": [671, 186, 770, 186, 769, 236, 670, 235], "text": "FDA"}, {"boundingBox": [787, 186, 1000, 187, 998, 238, 786, 236], "text": "Response"}, {"boundingBox": [1008, 187, 1193, 190, 1191, 238, 1007, 238], "text": "Strategy"}]}, {"boundingBox": [277, 308, 647, 307, 648, 344, 278, 345], "text": "1.0: INTRODUCTION", "words": [{"boundingBox": [279, 309, 345, 309, 344, 345, 278, 345], "text": "1.0:"}, {"boundingBox": [352, 309, 640, 310, 640, 344, 351, 345], "text": "INTRODUCTION"}]}, {"boundingBox": [274, 486, 279, 371, 307, 373, 301, 488], "text": "VVY", "words": [{"boundingBox": [275, 476, 280, 384, 307, 386, 303, 477], "text": "VVY", "confidence": "Low"}]}, {"boundingBox": [280, 349, 677, 350, 677, 380, 280, 380], "text": ">Restate questions from FDA", "words": [{"boundingBox": [281, 350, 418, 352, 418, 379, 280, 380], "text": ">Restate", "confidence": "Low"}, {"boundingBox": [423, 353, 542, 353, 543, 379, 424, 379], "text": "questions"}, {"boundingBox": [548, 352, 604, 352, 605, 380, 549, 379], "text": "from"}, {"boundingBox": [616, 351, 675, 350, 677, 380, 617, 380], "text": "FDA"}]}, {"boundingBox": [318, 381, 1082, 383, 1081, 417, 317, 416], "text": "Raise feasibility issues - theoretical versus clinical questions", "words": [{"boundingBox": [323, 384, 394, 385, 394, 414, 322, 413], "text": "Raise"}, {"boundingBox": [400, 385, 524, 386, 524, 415, 399, 414], "text": "feasibility"}, {"boundingBox": [530, 386, 607, 387, 607, 416, 530, 416], "text": "issues"}, {"boundingBox": [612, 387, 631, 387, 632, 416, 613, 416], "text": "-"}, {"boundingBox": [637, 387, 768, 387, 769, 417, 637, 417], "text": "theoretical"}, {"boundingBox": [774, 387, 857, 386, 858, 417, 775, 417], "text": "versus"}, {"boundingBox": [862, 386, 955, 385, 956, 417, 864, 417], "text": "clinical"}, {"boundingBox": [960, 385, 1081, 383, 1083, 417, 962, 417], "text": "questions"}]}, {"boundingBox": [322, 419, 1080, 421, 1079, 453, 321, 452], "text": "Summarize assessment and action plan around each question", "words": [{"boundingBox": [326, 421, 466, 422, 464, 452, 324, 450], "text": "Summarize"}, {"boundingBox": [472, 422, 613, 423, 612, 453, 470, 452], "text": "assessment"}, {"boundingBox": [619, 423, 665, 423, 664, 453, 618, 453], "text": "and"}, {"boundingBox": [670, 423, 747, 423, 747, 454, 670, 453], "text": "action"}, {"boundingBox": [753, 423, 808, 423, 808, 454, 752, 454], "text": "plan"}, {"boundingBox": [814, 423, 902, 422, 902, 454, 814, 454], "text": "around"}, {"boundingBox": [908, 422, 965, 422, 965, 454, 908, 454], "text": "each"}, {"boundingBox": [971, 422, 1078, 421, 1079, 453, 971, 454], "text": "question"}]}, {"boundingBox": [317, 454, 1376, 453, 1377, 486, 318, 488], "text": "Frame response as risk/benefit assessment of Actos clinical program (Frame broadly)", "words": [{"boundingBox": [324, 456, 404, 457, 403, 486, 323, 485], "text": "Frame"}, {"boundingBox": [410, 457, 520, 457, 519, 487, 409, 486], "text": "response"}, {"boundingBox": [526, 457, 554, 457, 553, 487, 525, 487], "text": "as"}, {"boundingBox": [560, 457, 704, 457, 703, 487, 559, 487], "text": "risk/benefit"}, {"boundingBox": [710, 457, 849, 456, 848, 488, 709, 487], "text": "assessment"}, {"boundingBox": [855, 456, 883, 456, 882, 488, 853, 488], "text": "of"}, {"boundingBox": [889, 456, 963, 456, 962, 488, 888, 488], "text": "Actos"}, {"boundingBox": [969, 456, 1060, 455, 1059, 488, 967, 488], "text": "clinical"}, {"boundingBox": [1066, 455, 1166, 455, 1165, 488, 1064, 488], "text": "program"}, {"boundingBox": [1178, 455, 1269, 454, 1267, 488, 1176, 488], "text": "(Frame"}, {"boundingBox": [1275, 454, 1377, 453, 1376, 487, 1273, 488], "text": "broadly)"}]}, {"boundingBox": [272, 490, 610, 492, 609, 527, 272, 526], "text": "2.0: NONCLINICAL", "words": [{"boundingBox": [277, 491, 344, 492, 344, 526, 277, 526], "text": "2.0:"}, {"boundingBox": [351, 492, 608, 493, 609, 527, 351, 526], "text": "NONCLINICAL"}]}, {"boundingBox": [271, 529, 472, 532, 471, 565, 270, 562], "text": "Key Messages:", "words": [{"boundingBox": [278, 530, 333, 532, 332, 563, 277, 563], "text": "Key"}, {"boundingBox": [339, 533, 471, 535, 469, 564, 338, 563], "text": "Messages:"}]}, {"boundingBox": [314, 569, 1385, 568, 1386, 598, 315, 599], "text": "Pivotal studies conducted by Takeda followed GLP's versus anecdotally reported", "words": [{"boundingBox": [324, 570, 418, 570, 419, 598, 325, 598], "text": "Pivotal"}, {"boundingBox": [424, 570, 518, 570, 518, 599, 424, 598], "text": "studies"}, {"boundingBox": [523, 570, 661, 570, 662, 599, 524, 599], "text": "conducted"}, {"boundingBox": [667, 570, 704, 569, 705, 599, 668, 599], "text": "by"}, {"boundingBox": [711, 569, 807, 569, 808, 600, 712, 599], "text": "Takeda"}, {"boundingBox": [812, 569, 927, 569, 928, 600, 814, 600], "text": "followed"}, {"boundingBox": [934, 569, 1011, 569, 1013, 600, 935, 600], "text": "GLP's", "confidence": "Low"}, {"boundingBox": [1017, 569, 1102, 569, 1103, 599, 1018, 600], "text": "versus"}, {"boundingBox": [1107, 569, 1260, 569, 1262, 599, 1109, 599], "text": "anecdotally"}, {"boundingBox": [1266, 569, 1384, 569, 1385, 598, 1267, 599], "text": "reported"}]}, {"boundingBox": [321, 605, 838, 606, 837, 634, 320, 633], "text": "promoter model studies, which did not.", "words": [{"boundingBox": [323, 607, 451, 606, 452, 634, 324, 634], "text": "promoter"}, {"boundingBox": [456, 606, 538, 606, 540, 635, 457, 634], "text": "model"}, {"boundingBox": [544, 606, 647, 606, 648, 635, 545, 635], "text": "studies,"}, {"boundingBox": [652, 606, 732, 606, 734, 634, 654, 635], "text": "which"}, {"boundingBox": [739, 606, 783, 607, 785, 634, 741, 634], "text": "did"}, {"boundingBox": [788, 607, 836, 607, 838, 634, 790, 634], "text": "not."}]}, {"boundingBox": [312, 637, 1351, 635, 1352, 670, 313, 671], "text": "Rat findings not duplicated in mouse, monkey, or dog. Therefore, the findings", "words": [{"boundingBox": [325, 639, 373, 639, 373, 669, 324, 668], "text": "Rat"}, {"boundingBox": [379, 639, 487, 640, 487, 670, 378, 669], "text": "findings"}, {"boundingBox": [493, 640, 543, 640, 543, 670, 493, 670], "text": "not"}, {"boundingBox": [549, 640, 686, 640, 686, 671, 549, 670], "text": "duplicated"}, {"boundingBox": [692, 640, 721, 640, 721, 671, 692, 671], "text": "in"}, {"boundingBox": [727, 640, 820, 640, 820, 671, 727, 671], "text": "mouse,"}, {"boundingBox": [825, 640, 939, 640, 940, 671, 825, 671], "text": "monkey,"}, {"boundingBox": [945, 640, 980, 639, 980, 671, 945, 671], "text": "or"}, {"boundingBox": [986, 639, 1050, 639, 1050, 671, 986, 671], "text": "dog."}, {"boundingBox": [1057, 639, 1195, 638, 1195, 670, 1058, 671], "text": "Therefore,"}, {"boundingBox": [1200, 638, 1243, 637, 1243, 670, 1201, 670], "text": "the"}, {"boundingBox": [1249, 637, 1351, 636, 1352, 669, 1249, 670], "text": "findings"}]}, {"boundingBox": [318, 674, 1413, 671, 1413, 703, 319, 707], "text": "appear to be species specific and not relevant to humans (Rat studies - females had", "words": [{"boundingBox": [323, 675, 418, 675, 418, 706, 323, 706], "text": "appear"}, {"boundingBox": [424, 675, 450, 675, 450, 706, 424, 706], "text": "to"}, {"boundingBox": [456, 675, 491, 675, 491, 706, 456, 706], "text": "be"}, {"boundingBox": [497, 675, 590, 676, 590, 706, 497, 706], "text": "species"}, {"boundingBox": [596, 676, 695, 676, 695, 706, 596, 706], "text": "specific"}, {"boundingBox": [701, 676, 751, 675, 751, 706, 701, 706], "text": "and"}, {"boundingBox": [757, 675, 804, 675, 804, 706, 757, 706], "text": "not"}, {"boundingBox": [810, 675, 919, 675, 919, 705, 810, 706], "text": "relevant"}, {"boundingBox": [925, 675, 951, 675, 951, 705, 925, 705], "text": "to"}, {"boundingBox": [957, 675, 1064, 674, 1064, 705, 957, 705], "text": "humans"}, {"boundingBox": [1070, 674, 1131, 674, 1131, 704, 1070, 705], "text": "(Rat"}, {"boundingBox": [1137, 674, 1230, 673, 1229, 704, 1137, 704], "text": "studies"}, {"boundingBox": [1236, 673, 1254, 673, 1254, 704, 1236, 704], "text": "-"}, {"boundingBox": [1260, 673, 1359, 672, 1359, 703, 1260, 703], "text": "females"}, {"boundingBox": [1365, 672, 1413, 671, 1413, 702, 1365, 703], "text": "had"}]}, {"boundingBox": [321, 706, 596, 710, 595, 740, 320, 737], "text": "benign tumors only)", "words": [{"boundingBox": [324, 707, 415, 709, 415, 738, 323, 737], "text": "benign"}, {"boundingBox": [421, 709, 516, 710, 517, 739, 421, 738], "text": "tumors"}, {"boundingBox": [522, 710, 594, 710, 595, 739, 523, 739], "text": "only)"}]}, {"boundingBox": [281, 738, 1373, 740, 1372, 774, 280, 773], "text": "Clinical and post-marketing data to date shows a very low incidence of bladder", "words": [{"boundingBox": [325, 741, 427, 742, 428, 771, 325, 770], "text": "Clinical"}, {"boundingBox": [433, 742, 486, 742, 486, 772, 433, 771], "text": "and"}, {"boundingBox": [492, 743, 699, 743, 699, 774, 492, 772], "text": "post-marketing"}, {"boundingBox": [708, 743, 763, 743, 763, 774, 708, 774], "text": "data"}, {"boundingBox": [769, 743, 798, 743, 798, 774, 769, 774], "text": "to"}, {"boundingBox": [807, 743, 860, 743, 861, 774, 808, 774], "text": "date"}, {"boundingBox": [866, 743, 947, 743, 947, 775, 866, 775], "text": "shows"}, {"boundingBox": [952, 743, 971, 743, 971, 775, 953, 775], "text": "a"}, {"boundingBox": [978, 743, 1035, 743, 1035, 775, 978, 775], "text": "very"}, {"boundingBox": [1040, 743, 1084, 742, 1085, 775, 1041, 775], "text": "low"}, {"boundingBox": [1095, 742, 1222, 741, 1222, 774, 1096, 774], "text": "incidence"}, {"boundingBox": [1227, 741, 1255, 741, 1255, 774, 1228, 774], "text": "of"}, {"boundingBox": [1260, 741, 1369, 740, 1369, 773, 1261, 774], "text": "bladder"}]}, {"boundingBox": [322, 776, 1251, 778, 1250, 811, 321, 809], "text": "cancer and strengthens argument that rat findings are species specific.", "words": [{"boundingBox": [324, 780, 413, 780, 414, 807, 324, 806], "text": "cancer"}, {"boundingBox": [418, 780, 470, 779, 471, 807, 419, 807], "text": "and"}, {"boundingBox": [475, 779, 632, 778, 632, 809, 476, 808], "text": "strengthens"}, {"boundingBox": [637, 778, 768, 778, 768, 809, 638, 809], "text": "argument"}, {"boundingBox": [773, 778, 828, 778, 829, 810, 774, 809], "text": "that"}, {"boundingBox": [833, 778, 876, 778, 877, 810, 834, 810], "text": "rat"}, {"boundingBox": [882, 778, 990, 778, 990, 811, 882, 810], "text": "findings"}, {"boundingBox": [995, 778, 1042, 778, 1042, 811, 996, 811], "text": "are"}, {"boundingBox": [1047, 778, 1140, 778, 1140, 811, 1047, 811], "text": "species"}, {"boundingBox": [1145, 778, 1250, 778, 1250, 812, 1145, 811], "text": "specific."}]}, {"boundingBox": [278, 847, 561, 849, 560, 881, 277, 878], "text": "Supporting arguments", "words": [{"boundingBox": [280, 847, 415, 849, 415, 879, 280, 879], "text": "Supporting"}, {"boundingBox": [421, 849, 560, 851, 561, 880, 422, 879], "text": "arguments"}]}, {"boundingBox": [275, 878, 1006, 880, 1005, 915, 274, 914], "text": ">Question source of pioglitazone used by Novo Nordisk", "words": [{"boundingBox": [279, 880, 437, 881, 436, 914, 278, 912], "text": ">Question", "confidence": "Low"}, {"boundingBox": [443, 881, 525, 882, 524, 915, 442, 914], "text": "source"}, {"boundingBox": [531, 882, 557, 882, 556, 915, 530, 915], "text": "of"}, {"boundingBox": [563, 882, 717, 882, 717, 915, 562, 915], "text": "pioglitazone"}, {"boundingBox": [723, 882, 781, 882, 781, 915, 723, 915], "text": "used"}, {"boundingBox": [787, 882, 819, 882, 819, 915, 787, 915], "text": "by"}, {"boundingBox": [826, 882, 896, 881, 896, 915, 826, 915], "text": "Novo"}, {"boundingBox": [903, 881, 1005, 880, 1006, 914, 903, 915], "text": "Nordisk"}]}, {"boundingBox": [272, 912, 932, 915, 931, 949, 271, 946], "text": "Examine bladder concentrations in rodent studies", "words": [{"boundingBox": [323, 913, 434, 914, 433, 947, 323, 946], "text": "Examine"}, {"boundingBox": [440, 914, 533, 915, 533, 948, 440, 948], "text": "bladder"}, {"boundingBox": [540, 915, 721, 917, 721, 948, 539, 948], "text": "concentrations"}, {"boundingBox": [728, 917, 752, 917, 752, 948, 727, 948], "text": "in"}, {"boundingBox": [759, 917, 843, 917, 842, 948, 758, 948], "text": "rodent"}, {"boundingBox": [850, 917, 931, 917, 931, 947, 849, 948], "text": "studies"}]}, {"boundingBox": [268, 951, 686, 952, 685, 989, 267, 987], "text": "3.0; PPAR MECHANISM", "words": [{"boundingBox": [277, 952, 336, 952, 336, 988, 277, 988], "text": "3.0;"}, {"boundingBox": [343, 952, 437, 952, 437, 988, 343, 988], "text": "PPAR"}, {"boundingBox": [449, 952, 671, 953, 672, 990, 449, 988], "text": "MECHANISM"}]}, {"boundingBox": [272, 991, 425, 992, 424, 1026, 271, 1024], "text": "Key Points:", "words": [{"boundingBox": [276, 991, 328, 993, 328, 1025, 277, 1025], "text": "Key"}, {"boundingBox": [335, 993, 425, 995, 423, 1025, 334, 1025], "text": "Points:"}]}, {"boundingBox": [273, 1025, 1365, 1027, 1364, 1062, 272, 1060], "text": "Revalidate Sam Cohen's original hypothesis 1996, using 1999 EMEA argument for", "words": [{"boundingBox": [322, 1026, 458, 1027, 458, 1059, 321, 1057], "text": "Revalidate"}, {"boundingBox": [464, 1027, 512, 1028, 512, 1060, 464, 1059], "text": "Sam"}, {"boundingBox": [525, 1028, 631, 1028, 631, 1061, 524, 1060], "text": "Cohen's"}, {"boundingBox": [637, 1028, 733, 1029, 733, 1062, 637, 1061], "text": "original"}, {"boundingBox": [739, 1029, 876, 1029, 876, 1062, 739, 1062], "text": "hypothesis"}, {"boundingBox": [882, 1029, 950, 1029, 950, 1062, 882, 1062], "text": "1996,"}, {"boundingBox": [956, 1029, 1028, 1029, 1029, 1062, 956, 1062], "text": "using"}, {"boundingBox": [1034, 1029, 1096, 1029, 1097, 1062, 1035, 1062], "text": "1999"}, {"boundingBox": [1102, 1028, 1189, 1028, 1190, 1061, 1103, 1061], "text": "EMEA"}, {"boundingBox": [1197, 1028, 1315, 1027, 1316, 1059, 1198, 1061], "text": "argument"}, {"boundingBox": [1321, 1027, 1363, 1027, 1364, 1059, 1322, 1059], "text": "for"}]}, {"boundingBox": [322, 1064, 419, 1066, 419, 1095, 321, 1093], "text": "support", "words": [{"boundingBox": [325, 1065, 419, 1067, 419, 1095, 324, 1093], "text": "support"}]}, {"boundingBox": [278, 1095, 618, 1098, 617, 1129, 277, 1127], "text": "Background on PPARs", "words": [{"boundingBox": [323, 1098, 477, 1100, 478, 1129, 323, 1127], "text": "Background"}, {"boundingBox": [483, 1100, 514, 1099, 515, 1130, 484, 1129], "text": "on"}, {"boundingBox": [520, 1099, 618, 1098, 618, 1129, 521, 1130], "text": "PPARs"}]}, {"boundingBox": [321, 1132, 780, 1133, 779, 1168, 321, 1168], "text": ">Dual versus gamma versus alpha", "words": [{"boundingBox": [324, 1133, 429, 1135, 429, 1166, 323, 1168], "text": ">Dual", "confidence": "Low"}, {"boundingBox": [436, 1136, 516, 1137, 515, 1165, 436, 1165], "text": "versus"}, {"boundingBox": [523, 1137, 616, 1137, 616, 1165, 522, 1164], "text": "gamma"}, {"boundingBox": [623, 1137, 702, 1136, 703, 1166, 623, 1165], "text": "versus"}, {"boundingBox": [709, 1136, 779, 1135, 780, 1168, 710, 1166], "text": "alpha"}]}, {"boundingBox": [365, 1164, 484, 1169, 482, 1202, 364, 1198], "text": "Structure", "words": [{"boundingBox": [370, 1165, 484, 1171, 483, 1202, 368, 1198], "text": "Structure"}]}, {"boundingBox": [320, 1199, 1139, 1204, 1138, 1239, 319, 1235], "text": ">Mechanism of action, in particular urinary tract tumorigenesis", "words": [{"boundingBox": [325, 1200, 510, 1203, 510, 1236, 325, 1233], "text": ">Mechanism", "confidence": "Low"}, {"boundingBox": [521, 1203, 547, 1203, 547, 1236, 521, 1236], "text": "of"}, {"boundingBox": [554, 1203, 640, 1204, 640, 1237, 554, 1236], "text": "action,"}, {"boundingBox": [646, 1204, 672, 1204, 672, 1237, 646, 1237], "text": "in"}, {"boundingBox": [679, 1204, 795, 1205, 796, 1238, 679, 1237], "text": "particular"}, {"boundingBox": [802, 1205, 892, 1205, 893, 1238, 802, 1238], "text": "urinary"}, {"boundingBox": [899, 1205, 957, 1205, 958, 1238, 899, 1238], "text": "tract"}, {"boundingBox": [964, 1205, 1139, 1204, 1139, 1236, 964, 1238], "text": "tumorigenesis"}]}, {"boundingBox": [309, 1238, 539, 1237, 540, 1269, 310, 1270], "text": "Promoter models", "words": [{"boundingBox": [322, 1238, 439, 1238, 438, 1270, 322, 1271], "text": "Promoter"}, {"boundingBox": [445, 1238, 539, 1241, 536, 1269, 444, 1270], "text": "models"}]}, {"boundingBox": [318, 1271, 1084, 1273, 1083, 1306, 317, 1305], "text": "> Application of model to standard acceptable GLP models", "words": [{"boundingBox": [325, 1272, 347, 1272, 347, 1305, 325, 1305], "text": ">"}, {"boundingBox": [371, 1272, 516, 1273, 516, 1306, 371, 1305], "text": "Application"}, {"boundingBox": [522, 1273, 549, 1273, 549, 1306, 522, 1306], "text": "of"}, {"boundingBox": [555, 1273, 635, 1274, 634, 1306, 555, 1306], "text": "model"}, {"boundingBox": [641, 1274, 670, 1274, 670, 1306, 641, 1306], "text": "to"}, {"boundingBox": [676, 1274, 780, 1274, 779, 1306, 676, 1306], "text": "standard"}, {"boundingBox": [786, 1274, 918, 1274, 918, 1306, 786, 1306], "text": "acceptable"}, {"boundingBox": [925, 1274, 982, 1274, 981, 1306, 924, 1306], "text": "GLP"}, {"boundingBox": [989, 1274, 1083, 1273, 1083, 1306, 988, 1306], "text": "models"}]}, {"boundingBox": [273, 1306, 415, 1307, 414, 1336, 272, 1335], "text": "NN622", "words": [{"boundingBox": [323, 1307, 415, 1309, 415, 1337, 323, 1336], "text": "NN622"}]}, {"boundingBox": [348, 1342, 1033, 1345, 1032, 1377, 347, 1375], "text": "Compare/contrast structure of pioglitazone to NN622", "words": [{"boundingBox": [369, 1343, 592, 1346, 593, 1376, 370, 1373], "text": "Compare/contrast"}, {"boundingBox": [598, 1346, 707, 1347, 708, 1376, 599, 1376], "text": "structure"}, {"boundingBox": [713, 1347, 738, 1347, 739, 1376, 714, 1376], "text": "of"}, {"boundingBox": [744, 1347, 900, 1346, 901, 1376, 745, 1376], "text": "pioglitazone"}, {"boundingBox": [906, 1346, 931, 1346, 933, 1376, 907, 1376], "text": "to"}, {"boundingBox": [937, 1346, 1030, 1345, 1032, 1374, 939, 1375], "text": "NN622"}]}, {"boundingBox": [311, 1377, 1234, 1379, 1233, 1412, 310, 1410], "text": "Determine correlation between fibrates and bladder cancer (Section 6.0?)", "words": [{"boundingBox": [321, 1378, 452, 1380, 454, 1410, 322, 1409], "text": "Determine"}, {"boundingBox": [458, 1380, 596, 1381, 598, 1411, 460, 1410], "text": "correlation"}, {"boundingBox": [602, 1381, 708, 1381, 710, 1412, 604, 1411], "text": "between"}, {"boundingBox": [714, 1381, 806, 1381, 808, 1412, 716, 1412], "text": "fibrates"}, {"boundingBox": [812, 1381, 860, 1381, 862, 1412, 814, 1412], "text": "and"}, {"boundingBox": [866, 1381, 962, 1381, 964, 1412, 868, 1412], "text": "bladder"}, {"boundingBox": [968, 1381, 1048, 1380, 1050, 1412, 970, 1412], "text": "cancer"}, {"boundingBox": [1054, 1380, 1160, 1379, 1162, 1411, 1056, 1412], "text": "(Section"}, {"boundingBox": [1166, 1379, 1232, 1379, 1234, 1411, 1168, 1411], "text": "6.0?)"}]}, {"boundingBox": [318, 1411, 1401, 1411, 1401, 1446, 319, 1447], "text": "Determine correlation between PPAR-alpha agonists and bladder cancer (Section 6.0?)", "words": [{"boundingBox": [322, 1413, 455, 1415, 454, 1445, 321, 1444], "text": "Determine"}, {"boundingBox": [461, 1415, 597, 1416, 597, 1447, 460, 1445], "text": "correlation"}, {"boundingBox": [603, 1416, 708, 1416, 707, 1447, 603, 1447], "text": "between"}, {"boundingBox": [714, 1416, 871, 1416, 870, 1448, 713, 1447], "text": "PPAR-alpha"}, {"boundingBox": [877, 1416, 979, 1416, 979, 1448, 876, 1448], "text": "agonists"}, {"boundingBox": [985, 1416, 1031, 1415, 1031, 1448, 985, 1448], "text": "and"}, {"boundingBox": [1037, 1415, 1132, 1414, 1132, 1447, 1037, 1448], "text": "bladder"}, {"boundingBox": [1138, 1414, 1220, 1413, 1220, 1447, 1138, 1447], "text": "cancer"}, {"boundingBox": [1226, 1413, 1331, 1412, 1331, 1446, 1226, 1447], "text": "(Section"}, {"boundingBox": [1337, 1412, 1401, 1411, 1401, 1446, 1337, 1446], "text": "6.0?)"}]}, {"boundingBox": [319, 1448, 1110, 1449, 1109, 1482, 318, 1481], "text": "Argument will answer FDA's theoretical hypotheses with facts", "words": [{"boundingBox": [325, 1449, 450, 1449, 450, 1482, 325, 1480], "text": "Argument"}, {"boundingBox": [456, 1449, 504, 1449, 504, 1482, 456, 1482], "text": "will"}, {"boundingBox": [510, 1449, 600, 1450, 601, 1483, 510, 1482], "text": "answer"}, {"boundingBox": [606, 1450, 693, 1450, 693, 1483, 607, 1483], "text": "FDA's"}, {"boundingBox": [699, 1450, 830, 1450, 830, 1483, 699, 1483], "text": "theoretical"}, {"boundingBox": [836, 1450, 976, 1450, 977, 1482, 836, 1483], "text": "hypotheses"}, {"boundingBox": [982, 1450, 1039, 1450, 1040, 1481, 983, 1482], "text": "with"}, {"boundingBox": [1045, 1450, 1107, 1450, 1108, 1481, 1046, 1481], "text": "facts"}]}, {"boundingBox": [272, 1484, 530, 1487, 529, 1524, 272, 1522], "text": "4.0: CLINICAL", "words": [{"boundingBox": [278, 1485, 346, 1487, 346, 1521, 277, 1522], "text": "4.0:"}, {"boundingBox": [354, 1487, 529, 1489, 529, 1524, 353, 1521], "text": "CLINICAL"}]}, {"boundingBox": [270, 1523, 469, 1528, 468, 1562, 269, 1557], "text": "Key Message:", "words": [{"boundingBox": [277, 1524, 329, 1525, 329, 1559, 277, 1558], "text": "Key"}, {"boundingBox": [336, 1525, 469, 1531, 468, 1561, 336, 1559], "text": "Message:"}]}, {"boundingBox": [274, 1557, 1362, 1559, 1361, 1593, 273, 1592], "text": "Epidemiological evaluations strongly indicate that there is no increased risk of", "words": [{"boundingBox": [324, 1559, 536, 1562, 537, 1592, 325, 1591], "text": "Epidemiological", "confidence": "Low"}, {"boundingBox": [542, 1562, 694, 1562, 696, 1593, 544, 1592], "text": "evaluations"}, {"boundingBox": [701, 1562, 809, 1563, 810, 1593, 702, 1593], "text": "strongly"}, {"boundingBox": [815, 1563, 923, 1563, 925, 1594, 817, 1593], "text": "indicate"}, {"boundingBox": [930, 1563, 984, 1562, 985, 1593, 931, 1594], "text": "that"}, {"boundingBox": [990, 1562, 1059, 1562, 1060, 1593, 992, 1593], "text": "there"}, {"boundingBox": [1065, 1562, 1088, 1562, 1090, 1593, 1067, 1593], "text": "is"}, {"boundingBox": [1094, 1562, 1127, 1562, 1129, 1593, 1096, 1593], "text": "no"}, {"boundingBox": [1134, 1561, 1261, 1560, 1263, 1593, 1135, 1593], "text": "increased"}, {"boundingBox": [1267, 1560, 1319, 1560, 1321, 1592, 1269, 1593], "text": "risk"}, {"boundingBox": [1325, 1560, 1361, 1559, 1363, 1592, 1327, 1592], "text": "of"}]}, {"boundingBox": [315, 1596, 1429, 1598, 1428, 1629, 314, 1628], "text": "bladder cancer associated with pioglitazone. Frequency of bladder cancer incidents", "words": [{"boundingBox": [321, 1597, 426, 1597, 428, 1628, 322, 1627], "text": "bladder"}, {"boundingBox": [432, 1597, 522, 1598, 523, 1628, 434, 1628], "text": "cancer"}, {"boundingBox": [528, 1598, 665, 1598, 666, 1629, 529, 1628], "text": "associated"}, {"boundingBox": [671, 1598, 730, 1598, 732, 1629, 672, 1629], "text": "with"}, {"boundingBox": [736, 1598, 915, 1598, 917, 1629, 738, 1629], "text": "pioglitazone."}, {"boundingBox": [921, 1598, 1062, 1598, 1064, 1629, 923, 1629], "text": "Frequency"}, {"boundingBox": [1068, 1598, 1096, 1598, 1098, 1629, 1070, 1629], "text": "of"}, {"boundingBox": [1102, 1598, 1207, 1598, 1209, 1629, 1104, 1629], "text": "bladder"}, {"boundingBox": [1213, 1598, 1300, 1598, 1302, 1629, 1215, 1629], "text": "cancer"}, {"boundingBox": [1306, 1598, 1428, 1598, 1429, 1628, 1308, 1629], "text": "incidents"}]}, {"boundingBox": [324, 1629, 1392, 1632, 1391, 1665, 323, 1663], "text": "in ACTOS trials is in line with the frequency observed in the general population.", "words": [{"boundingBox": [324, 1630, 349, 1630, 350, 1662, 325, 1662], "text": "in"}, {"boundingBox": [355, 1630, 465, 1632, 466, 1663, 356, 1662], "text": "ACTOS"}, {"boundingBox": [471, 1632, 538, 1632, 539, 1664, 472, 1663], "text": "trials"}, {"boundingBox": [545, 1632, 568, 1633, 569, 1664, 545, 1664], "text": "is"}, {"boundingBox": [574, 1633, 601, 1633, 602, 1664, 575, 1664], "text": "in"}, {"boundingBox": [608, 1633, 658, 1633, 659, 1664, 609, 1664], "text": "line"}, {"boundingBox": [665, 1634, 725, 1634, 726, 1665, 665, 1664], "text": "with"}, {"boundingBox": [732, 1634, 774, 1634, 775, 1665, 733, 1665], "text": "the"}, {"boundingBox": [780, 1634, 913, 1635, 914, 1665, 781, 1665], "text": "frequency"}, {"boundingBox": [919, 1635, 1039, 1634, 1040, 1665, 920, 1665], "text": "observed"}, {"boundingBox": [1045, 1634, 1072, 1634, 1074, 1665, 1046, 1665], "text": "in"}, {"boundingBox": [1079, 1634, 1123, 1634, 1124, 1665, 1080, 1665], "text": "the"}, {"boundingBox": [1129, 1634, 1226, 1634, 1227, 1664, 1130, 1665], "text": "general"}, {"boundingBox": [1232, 1634, 1390, 1632, 1391, 1663, 1234, 1664], "text": "population."}]}, {"boundingBox": [276, 1666, 1428, 1666, 1428, 1700, 277, 1701], "text": "Monitoring is not possible because it in unreliable (not sensitive enough, many false", "words": [{"boundingBox": [321, 1669, 475, 1669, 477, 1699, 323, 1698], "text": "Monitoring", "confidence": "Low"}, {"boundingBox": [481, 1669, 504, 1669, 505, 1700, 482, 1700], "text": "is"}, {"boundingBox": [510, 1669, 554, 1669, 555, 1700, 511, 1700], "text": "not"}, {"boundingBox": [560, 1670, 667, 1670, 669, 1701, 561, 1700], "text": "possible"}, {"boundingBox": [673, 1670, 777, 1670, 778, 1701, 674, 1701], "text": "because"}, {"boundingBox": [783, 1670, 804, 1670, 805, 1701, 784, 1701], "text": "it"}, {"boundingBox": [810, 1670, 838, 1670, 839, 1701, 811, 1701], "text": "in"}, {"boundingBox": [844, 1670, 979, 1669, 980, 1701, 845, 1701], "text": "unreliable"}, {"boundingBox": [984, 1669, 1042, 1669, 1043, 1701, 985, 1701], "text": "(not"}, {"boundingBox": [1048, 1669, 1161, 1668, 1162, 1700, 1049, 1701], "text": "sensitive"}, {"boundingBox": [1167, 1668, 1273, 1668, 1273, 1700, 1168, 1700], "text": "enough,"}, {"boundingBox": [1279, 1668, 1354, 1667, 1354, 1699, 1279, 1700], "text": "many"}, {"boundingBox": [1359, 1667, 1423, 1666, 1423, 1699, 1360, 1699], "text": "false"}]}, {"boundingBox": [321, 1700, 1053, 1701, 1052, 1735, 320, 1734], "text": "positives). There may also be ethical and logistic issues.", "words": [{"boundingBox": [323, 1703, 465, 1702, 466, 1734, 324, 1733], "text": "positives)."}, {"boundingBox": [473, 1702, 550, 1702, 550, 1734, 474, 1734], "text": "There"}, {"boundingBox": [556, 1702, 615, 1701, 615, 1735, 556, 1734], "text": "may"}, {"boundingBox": [621, 1701, 674, 1701, 675, 1735, 621, 1735], "text": "also"}, {"boundingBox": [680, 1701, 714, 1701, 714, 1735, 680, 1735], "text": "be"}, {"boundingBox": [720, 1701, 808, 1702, 809, 1735, 720, 1735], "text": "ethical"}, {"boundingBox": [814, 1702, 866, 1702, 866, 1735, 814, 1735], "text": "and"}, {"boundingBox": [872, 1702, 966, 1703, 966, 1735, 872, 1735], "text": "logistic"}, {"boundingBox": [972, 1703, 1053, 1703, 1053, 1735, 972, 1735], "text": "issues."}]}, {"boundingBox": [272, 1769, 560, 1770, 559, 1804, 272, 1804], "text": "Supporting arguments", "words": [{"boundingBox": [277, 1770, 414, 1773, 413, 1804, 277, 1805], "text": "Supporting"}, {"boundingBox": [421, 1773, 559, 1773, 559, 1804, 420, 1804], "text": "arguments"}]}, {"boundingBox": [275, 1801, 1303, 1802, 1302, 1838, 274, 1837], "text": "> Forms of monitoring done [US (011,031), EU, IP (OCT020)], investigate what", "words": [{"boundingBox": [277, 1803, 298, 1804, 298, 1833, 277, 1833], "text": ">"}, {"boundingBox": [323, 1804, 403, 1804, 403, 1835, 323, 1833], "text": "Forms"}, {"boundingBox": [409, 1804, 438, 1805, 437, 1835, 409, 1835], "text": "of"}, {"boundingBox": [443, 1805, 585, 1805, 584, 1837, 443, 1835], "text": "monitoring"}, {"boundingBox": [592, 1805, 651, 1805, 651, 1837, 592, 1837], "text": "done"}, {"boundingBox": [657, 1805, 709, 1805, 708, 1838, 657, 1837], "text": "[US"}, {"boundingBox": [714, 1805, 846, 1805, 846, 1838, 714, 1838], "text": "(011,031),", "confidence": "Low"}, {"boundingBox": [852, 1805, 901, 1805, 901, 1838, 851, 1838], "text": "EU,"}, {"boundingBox": [907, 1805, 937, 1805, 937, 1838, 907, 1838], "text": "IP", "confidence": "Low"}, {"boundingBox": [943, 1805, 1092, 1804, 1092, 1837, 943, 1838], "text": "(OCT020)],"}, {"boundingBox": [1098, 1804, 1235, 1803, 1235, 1836, 1098, 1837], "text": "investigate"}, {"boundingBox": [1241, 1803, 1302, 1802, 1302, 1835, 1241, 1836], "text": "what"}]}, {"boundingBox": [321, 1838, 1027, 1842, 1026, 1873, 320, 1869], "text": "worked/what didn't without invalidating what was done", "words": [{"boundingBox": [323, 1838, 489, 1840, 489, 1871, 324, 1868], "text": "worked/what"}, {"boundingBox": [494, 1840, 568, 1841, 569, 1871, 495, 1871], "text": "didn't"}, {"boundingBox": [574, 1841, 672, 1842, 672, 1872, 574, 1871], "text": "without"}, {"boundingBox": [678, 1842, 826, 1842, 825, 1872, 677, 1872], "text": "invalidating"}, {"boundingBox": [832, 1842, 896, 1843, 895, 1872, 831, 1872], "text": "what"}, {"boundingBox": [902, 1843, 953, 1843, 951, 1872, 901, 1872], "text": "was"}, {"boundingBox": [958, 1843, 1023, 1843, 1021, 1871, 957, 1872], "text": "done"}]}, {"boundingBox": [275, 1872, 1429, 1877, 1428, 1911, 274, 1906], "text": "Additional assessments of data - Searching current clinical and post-marketing databases", "words": [{"boundingBox": [324, 1874, 455, 1875, 457, 1905, 326, 1903], "text": "Additional", "confidence": "Low"}, {"boundingBox": [460, 1875, 615, 1876, 616, 1907, 462, 1905], "text": "assessments"}, {"boundingBox": [620, 1876, 653, 1876, 654, 1908, 622, 1908], "text": "of"}, {"boundingBox": [659, 1876, 708, 1876, 709, 1908, 660, 1908], "text": "data", "confidence": "Low"}, {"boundingBox": [713, 1876, 733, 1876, 734, 1909, 714, 1908], "text": "-"}, {"boundingBox": [739, 1876, 862, 1877, 863, 1910, 740, 1909], "text": "Searching"}, {"boundingBox": [868, 1877, 957, 1877, 958, 1910, 869, 1910], "text": "current"}, {"boundingBox": [962, 1877, 1055, 1877, 1056, 1910, 963, 1910], "text": "clinical"}, {"boundingBox": [1060, 1877, 1108, 1877, 1108, 1910, 1061, 1910], "text": "and"}, {"boundingBox": [1113, 1877, 1302, 1877, 1303, 1909, 1114, 1910], "text": "post-marketing"}, {"boundingBox": [1309, 1877, 1428, 1877, 1428, 1908, 1310, 1909], "text": "databases"}]}, {"boundingBox": [271, 1971, 587, 1973, 587, 2004, 270, 2002], "text": "Last revision: August 7, 2002", "words": [{"boundingBox": [274, 1975, 319, 1976, 321, 2001, 276, 2000], "text": "Last"}, {"boundingBox": [324, 1976, 419, 1977, 421, 2002, 326, 2001], "text": "revision:"}, {"boundingBox": [424, 1977, 501, 1976, 503, 2003, 425, 2002], "text": "August"}, {"boundingBox": [506, 1976, 525, 1975, 527, 2004, 507, 2003], "text": "7,"}, {"boundingBox": [530, 1975, 585, 1973, 586, 2004, 532, 2004], "text": "2002"}]}, {"boundingBox": [93, 2092, 554, 2093, 553, 2123, 92, 2122], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [93, 2092, 225, 2094, 225, 2123, 94, 2121], "text": "Confidential"}, {"boundingBox": [230, 2094, 246, 2095, 247, 2123, 231, 2123], "text": "-"}, {"boundingBox": [252, 2095, 335, 2095, 336, 2124, 252, 2123], "text": "Subject"}, {"boundingBox": [341, 2095, 362, 2095, 363, 2124, 341, 2124], "text": "to"}, {"boundingBox": [368, 2095, 480, 2095, 481, 2123, 368, 2124], "text": "Protective"}, {"boundingBox": [486, 2095, 553, 2094, 554, 2122, 486, 2123], "text": "Order"}]}, {"boundingBox": [1285, 2092, 1564, 2092, 1563, 2122, 1284, 2122], "text": "TAK-RAMSTM-00236226", "words": [{"boundingBox": [1291, 2092, 1562, 2093, 1563, 2122, 1291, 2123], "text": "TAK-RAMSTM-00236226"}]}, {"boundingBox": [1291, 2127, 1640, 2126, 1641, 2156, 1292, 2156], "text": "Produced in MDL on 09/18/12", "words": [{"boundingBox": [1293, 2128, 1402, 2130, 1402, 2157, 1292, 2157], "text": "Produced"}, {"boundingBox": [1408, 2130, 1430, 2130, 1430, 2156, 1408, 2157], "text": "in"}, {"boundingBox": [1436, 2130, 1492, 2130, 1492, 2157, 1436, 2156], "text": "MDL"}, {"boundingBox": [1497, 2130, 1529, 2130, 1530, 2157, 1498, 2157], "text": "on"}, {"boundingBox": [1534, 2130, 1638, 2127, 1640, 2157, 1535, 2157], "text": "09/18/12"}]}, {"boundingBox": [384, 2193, 1314, 2191, 1315, 2231, 385, 2232], "text": "Source: https://www.indupbodgroboots.ucsf.edu/docs/yljf0226", "words": [{"boundingBox": [390, 2195, 503, 2196, 504, 2231, 391, 2230], "text": "Source:"}, {"boundingBox": [509, 2196, 1312, 2192, 1314, 2229, 510, 2231], "text": "https://www.indupbodgroboots.ucsf.edu/docs/yljf0226", "confidence": "Low"}]}]}]}